Chenji Wang

29PUBLICATIONS
53CO-AUTHORS
Molecular targetsCancer cell biologyNeonatologySystem and network securityMedical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 25, 2026
TRAF7 mutations stabilize K/NRAS and hyperactivate MAPK signaling to cause CAFDADD neurodevelopmental defects.

|Jun 17, 2026
Correction: mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3IBTK-mediated ubiquitination of eIF4A1 in cancer cells.

|Jun 05, 2026
TSC22D4 drives clear cell renal cell carcinoma progression and therapy resistance by stabilizing NRF2 through KEAP1 disruption.

|Mar 14, 2026
DPP9 inhibition boosts antitumor immunity by disrupting BRISC-mediated PD-L1 expression in clear cell renal cell carcinoma.

Wei Zhang, Yue Wang, Tao Feng

|Mar 06, 2026
The TBCK-PPP1R21-FERRY3/C12orf4 complex: a RAB5-GAP brake essential for endo-lysosomal homeostasis.

Yingji Chen, Xiayun Xu, Yi Zheng

|Jul 23, 2025
Targeting the WSB2-NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors.

Dongyue Jiao, Kun Chang, Jiamin Jin

Pageof 5

Frequent Collaborators

8 joint publications

Shimin Zhao

8 joint publications

Kun Gao

6 joint publications

Yao Li

4 joint publications

Pingzhao Zhang